A good rule
Nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, bloating, and changes in appetite are among the most common early concerns
continued treatment helps maintain losses Common side effects that may affect treatment adherence include: Nausea and vomiting (usually temporary, improving after several weeks) Diarrhoea or constipation Abdominal discomfort Fatigue Injection site reactions Important safety considerations include: Risk of hypoglycaemia if used with insulin or sulfonylureas [4] Do not stop or reduce insulin rapidly without medical advice (risk of diabetic ketoacidosis) [4] Maintain adequate hydration to prevent acute kidney injury [4] Potential for gallbladder problems (pain, stones) Rare risk of intestinal obstruction Possible worsening of diabetic retinopathy in people with diabetes during rapid improvement in blood glucose For tirzepatide: use additional non-oral contraception for 4 weeks after initiation and each dose escalation Patients should contact their GP if they experience: persistent vomiting preventing fluid intake, severe abdominal pain, signs of gallbladder disease, or unusual thyroid symptoms
If youre ready to get started
You can get an official sharps container from a pharmacy or medical supply retailer
Cardiovascular Health : Some GLP-1 agonists have demonstrated protective effects on the cardiovascular system, reducing the risk of major adverse cardiovascular events (MACE)
